04/14/2025
6:08 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025
11:15 PM | ProQR Therapeutics (Filer)
| Form EFFECT | |
03/25/2025
3:37 PM | ProQR Therapeutics (Filer)
| Form 424B5 | |
03/13/2025
7:30 AM | ProQR Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
03/13/2025
7:31 AM | ProQR Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2025
6:00 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025
6:16 AM | ProQR Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/14/2025
5:12 PM | ProQR Therapeutics (Subject)
VAN HERK INVESTMENTS B.V. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:46 AM | Adage Capital Management, L.P. (Filed by)
ProQR Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/12/2024
7:22 AM | ProQR Therapeutics (Filer)
| Form 6-K/A | |
12/11/2024
6:07 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for PRQR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/10/2024
7:05 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
7:04 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024
6:02 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
3:07 PM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024
5:12 AM | ProQR Therapeutics (Filer)
| Form 424B5 | |
10/23/2024
5:18 AM | ProQR Therapeutics (Filer)
| Form 424B5 | |
10/10/2024
11:15 PM | ProQR Therapeutics (Filer)
| Form EFFECT | |
10/10/2024
3:18 PM | ProQR Therapeutics (Filer)
| Form 424B5 | |
09/30/2024
4:05 PM | ProQR Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/08/2024
6:01 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
3:19 PM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2024
6:02 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
7:07 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024
6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
6:06 AM | ProQR Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy PRQR Stock Free PRQR Stock Alerts